US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical ...

First-time disclosures session at ACS Fall 2026 debuted compounds designed to treat cancer, acne, urinary tract infections, and more ...

Dual-use concerns are always worth considering, but we’re more excited than worried about the sciences behind AI-generated ...

In our cells, countless RNA polymerase (RNAP) enzymes zip along our DNA, rotating and twirling in an elaborate molecular ...

Acetyl CoA carboxylase inhibitors have been investigated for treating acne and liver disease, but the discarded candidates ...

Jake Remacle, an R&D and technology service and development technologist at Dow, is the recipient of the 2026 ACS National ...

To break down ‘forever chemicals,’ bacteria and fungi need a way to avoid or evade their own toxic by-products ...

Innovations include recyclable polyurethanes, cleaner pharmaceutical manufacturing, sustainable crop protection, and more ...

Moderna’s vaccine, intismeran, is a personalized neoantigen vaccine. It delivers mRNA that encodes tumor-specific mutations ...

Ervebo have made it to the Democratic Republic of the Congo, but the vaccine is untested against the currently circulating ...

For many across the globe, access to clean water is not guaranteed. In recent years, atmospheric water harvesting has started ...

In the latest setback for low-carbon ammonia, the Australian natural gas development company Woodside Energy is launching a ...